[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"biomarker:bap1-gene":3},{"name":4,"total":5,"recruiting":6,"trials":7},"BAP1 Gene",5,4,[8,16,22,29,35],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT04515836","Olaparib in Patients With HRD Malignant Mesothelioma",[12],"Phase 2","RECRUITING","2026-08-26T02:18:45.196599Z","2026-05-05T02:43:28.298448Z",{"nct_id":17,"title":18,"phases":19,"status":13,"updated_at":20,"content_modified":21},"NCT03786796","Study of Olaparib in Metastatic Renal Cell Carcinoma Patients With DNA Repair Gene Mutations",[12],"2026-08-26T02:18:38.077159Z","2026-05-05T02:35:31.766251Z",{"nct_id":23,"title":24,"phases":25,"status":13,"updated_at":27,"content_modified":28},"NCT04104776","A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas",[26],"Phase 1\u002FPhase 2","2026-08-26T02:17:15.156099Z","2026-07-05T05:32:16.792523Z",{"nct_id":30,"title":31,"phases":32,"status":13,"updated_at":33,"content_modified":34},"NCT04390737","Evaluate the Safety and Clinical Activity of HH2853",[26],"2026-08-26T02:18:54.586325Z","2026-05-05T02:43:26.959800Z",{"nct_id":36,"title":37,"phases":38,"status":39,"updated_at":40,"content_modified":41},"NCT04550494","Measuring the Effects of Talazoparib in Patients With Advanced Cancer and DNA Repair Variations",[12],"ACTIVE_NOT_RECRUITING","2026-08-03T03:54:23.387833Z","2026-05-05T02:43:29.385344Z"]